A phase 2 study of bortezomib, cyclophosphamide, pegylated liposomal doxorubicin and dexamethasone for newly diagnosed multiple myeloma

A phase 2 study of bortezomib, cyclophosphamide, pegylated liposomal doxorubicin and dexamethasone for newly diagnosed multiple myeloma

Bibliographic Details
Main Authors: Becker, P S, Gooley, T A, Green, D J, Burwick, N, Kim, T Y, Kojouri, K, Inoue, Y, Moore, D J, Nelli, E, Dennie, T, Bensinger, W I
Format: Online
Language:English
Published: Nature Publishing Group 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916300/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916300/

Similar Items